Wednesday, October 5, 2011

Article Review: Thirty Years of HIV and AIDS: Future Challenges and Opportunities


Thirty Years of HIV and AIDS: Future Challenges and Opportunities


Summarize the article for us.
            This article is from the June 2011 issue of Annals of Internal Medicine. This article discusses the future challenges and opportunities in HIV and AIDS research. It also gave brief information about HIV and AIDS from the last 30 years.
            Experts say that 60 million people have been infected in the last 30 years, with 25 million people having died from the infection. An estimated 33 million are currently living with HIV or AIDS. Progress in basic and clinical research and prevention methods has been successful. This is in part due to the fact that researchers now understand HIV and its pathogenesis. Advancements include being able to rapidly and specifically diagnose infection, suppress HIV replication with antiretroviral therapy (ART), having nearly eliminated mother – child transmission in many parts of the developed world and reduced incidence of HIV infection in some developing – world settings.
            There are 3 essential research and implementation goals in HIV/AIDS research. The first is to provide currently available treatments quicker. The most important treatment is ART. The second goal is to explore approaches to eliminate HIV and to aggressively pursue a cure. The third goal is to develop new prevention tools that can be used with or enhance current approaches.
            Prior to ART, survival was measured in weeks and months. Patient care was diagnosis and treatment of the opportunistic infections and AIDS related cancers. Since 1987, 5 classes of antiretroviral drugs have become available. Combinations of these drugs suppress HIV replication in the body. Now, if a 20 year old is diagnosed and begins ART, they may live another 50 years.
            ART has limitations. In order to be successful, there must be daily dosing for the remainder of the patients life. Health care delivery systems must manage HIV treatment different than others.
            The US agenda for AIDS research includes cost – effective ways to increase HIV testing, maximize services, and increase adherence to treatments. This includes fully implementing the recommendations of the Center for Disease Control and Prevention on HIV testing. The agenda also includes establishing incentives for organizations that conduct testing.
            By September 2010, The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) alone provided ART to more than 3 million HIV-infected people, provided antiretroviral mother-child transmission prophylaxis to more than 600,000 and care to an estimated 11 million people, including orphans of AIDS patients.
            Approximately 2.5 million people are infected each year. This means for every 2 patients who begin ART, another 5 are infected. Approximately 1/3 of all HIV-infected patients needing ART are actually receiving it.
            There have been no documented cases of a true cure induced by ART. There has been 1 claim that an HIV – infected person was cured after receiving a stem cell transplant for leukemia. This claim does not present a practical approach for treatment but it does prove that under certain circumstances HIV can be controlled without ART.
            When discussing a cure for HIV, the important goals are developing a true cure with complete eradication of the virus and a functional cure (permanent suppression of the virus). The goals of HIV prevention are improving current methods; ART based prevention methods, and a HIV vaccine. There have been numerous attempts to create a vaccine.
            In the 30 years of known HIV/AIDS existence, there have been successes in research. However, there are many more advances to be researched and developed.

Were you aware about anything in this article?
          I was aware of ART and its success. I was also aware of the goal and trials of a cure for AIDS/HIV. I have heard of attempts at a HIV vaccine.

What are your comments about it i.e. was it interesting? Surprising? Shocking? Etc.
          I really enjoyed the article. It was interesting to read about the advancements made in 30 years. It was also interesting to read about the goals in research. I got a little lost when it came to the medical talk (cells, etc), but overall I understood the main ideas. 



Plagiarism:
Using someone else's work without giving proper credit, is plagiarism. If you use my work, please reference it.

No comments:

Post a Comment